Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Camford Capital
Menlo ParkPre-Seed–Series A
10 people
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series A
7 people
Belle Impact Fund
Grosse Pointe FarmsSeed–Series A$25K – $250K
3 people
CloudStone Capital
San MateoSeed–Series A
5 people
Curitas Ventures
StockholmSeed–Growth
5 people
Fir Capital
Nova LimaSeed–Growth$100K – $5M
8 people
FRC FUND MANAGEMENT S.À R.L.
ZagrebPre-Seed–Series A
11 people
Neurone Group
LuxembourgSeed–Late Stage
11 people
Northwestern Medicine Innovation, LLC
ChicagoSeed–Series A
11 people
Vesalius Biocapital Partners
LuxembourgSeed–Growth$11M
5 people
ExSight Ventures
New YorkPre-Seed–Series B
4 people
Jumpstart Nova
NashvilleSeed–Series A$250K – $4M
4 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Propagator Ventures
OsloSeed–Series A
7 people
Selvedge Venture
LondonPre-Seed–Series A
4 people
APOLLO PROJECTS
San FranciscoSeed–Series B
2 people
VTC Ventures
RoanokePre-Seed–Series A$200K – $1M
3 people
V8 Capital Partners
LagosSeed–Growth
7 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
Scientific Health Development
DallasPre-Seed–Series A$2M
5 people
Kendall Capital Partners
BostonSeed–Growth
7 people
NuFund Venture Group
San DiegoSeed–Growth$1M
7 people
SeedToB
SuwaneeSeed–Series A$500K – $1.5M
4 people
Berkeley Catalyst
BerkeleySeed–Series A
3 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.
















































































